Clinical StudyPercutaneous CT–Guided Sympathicolysis with Radiofrequency for the Treatment of Palmar Hyperhidrosis
Section snippets
Patient Selection
From March 2010 to September 2015, patients with severe PPHH were diagnosed and treated by the Department of Dermatology of a single institution. The diagnostic criteria for PPHH were excessive sweating of more than 6 months’ duration, bilateral and symmetric involvement of the eccrine glands, appearance of the symptoms before the age of 25 years, and positive family history (13). The participation criteria for the CT–guided percutaneous RF sympathicolysis technique included patients with PPHH
Technical Success and Radiation Dose Data
A total number of 139 procedures in 108 patients were analyzed. The procedure was performed successfully in almost all patients, with a technical success rate of 98.56%. In two cases, the procedure could not be performed at one level because of pain during RF administration (Table 1). The mean dose–length product of the procedure was 1,274.28 mGy·cm ± 1,223.77, and the mean effective dose was 17.06 mSv ± 17.14.
Immediate Efficacy
Of the 108 patients, the quantitative analysis data for 11 patients and qualitative
Discussion
The present study demonstrates that CT–guided percutaneous RF sympathicolysis of T2, T3, and T4 levels for the treatment of PPHH is a safe and effective procedure. Results showed an initial success rate of 98.56%, similar to the success rates of surgical intervention in the literature, which are reported to be between 95% and 97.4% 8, 9. Quantitative and qualitative assessment of the immediate efficacy of percutaneous treatment showed good results, with an average increase in palmar skin
References (29)
- et al.
Hyperhidrosis: evolving concepts and a comprehensive review
Surgeon
(2010) - et al.
Managing hyperhidrosis: emerging therapies
Dermatol Clin
(2014) - et al.
Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis—with emphasis on perioperative management (1,360 case analyses)
Surg Neurol
(1999) Clinical differentiation of primary from secondary hyperhidrosis
J Am Acad Dermatol
(2011)- et al.
CT-guided thoracic sympathetic blockade for palmar hyperhidrosis: Immediate results and postoperative quality of life
J Clin Neurosci
(2016) - et al.
Validity and reliability of the hyperhidrosis disease severity scale (HDSS)
J Am Acad Dermatol
(2004) - et al.
Influence of T3 or T4 sympathicotomy for palmar hyperhidrosis
Am J Surg
(2010) - et al.
T4 sympathectomy for palmar hyperhidrosis: looking for the right operation
Surgery
(2008) - et al.
Management of hyperhidrosis
Clin Cosmet Invest Dermatol
(2014) - et al.
Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins
Toxins
(2013)
Hyperhidrosis
Int J Dermatol
Palmoplantar hyperhidrosis: a therapeutic challenge
Am Fam Physician
Treatment of hyperhidrosis with botulinum toxin
Aesthet Surg J
Thoracic sympathicolysis for primary hyperhidrosis
Surg Endosc
Cited by (18)
Development and Validation of a Nomogram to Predict Recurrence of Primary Hyperhidrosis after CT-guided Percutaneous Radiofrequency Sympathectomy
2023, Journal of Vascular and Interventional RadiologyLong-term outcomes of bilateral thoracoscopic T3 sympathectomy for primary focal hyperhidrosis in children
2023, Journal of Pediatric SurgeryCitation Excerpt :Considering our excellent short- and long-term outcomes in a strictly pediatric population, we feel justified to continue using our current surgical approach. Novel techniques such as CT-guided sympathicolysis, have been proposed for primary palmar hyperhidrosis, however hold higher rates of CS and recurrence, however may avoid problems related to thoracoscopy such as postoperative pain [12,13]. We herein present the long-term outcomes of our pediatric patient population that underwent thoracoscopic bilateral T3 sympathectomy for focal palmar hyperhidrosis.
Percutaneous Radiofrequency Sympatholysis in the Treatment of Primary Palmar Hyperhidrosis: A Retrospective Case-Controlled Study of Rib-Based Anatomical Targeting
2023, Journal of Vascular and Interventional RadiologyCitation Excerpt :The aforementioned information and data were obtained from medical records, postprocedural outpatient follow-up visits, and questionnaires. According to the results reported by García-Barquín et al (15), the percentage of patients with severe PPHH (HDSS Grades III and IV) was 90.5% before treatment; however, it significantly decreased to 32.1% after percutaneous CT-guided sympathicolysis with RF. If rib-based percutaneous RF sympatholysis at different anatomic targets achieved the same treatment effect, a 2-tailed chi-square test was performed, and it was estimated that 32 patients were required to provide 90% power, with a Type I error probability of 0.05.
Regarding “Retroperitoneoscopic lumbar sympathectomy for plantar hyperhidrosis”
2018, Journal of Vascular SurgeryReply
2018, Journal of Vascular Surgery
None of the authors have identified a conflict of interest.